Tag: ticovac market forecast

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Ticovac Market?

The ticovac market is projected to expand due to the increasing incidence of tick-borne diseases. These diseases, which are transmitted to humans through tick bites, are on the rise because of climate change, expansion of tick habitats, increased human exposure, and improved diagnostics. Ticovac is used to create active immunity against tick-borne encephalitis (TBE), a serious viral infection spread through tick bites. For instance, in February 2024, the Centers for Disease Control and Prevention reported that the overall incidence of Lyme disease was 18.9 cases per 100,000 population. This was 68.8% higher than in previous years. Furthermore, the median rate among high-incidence jurisdictions was 58% higher at 68.3 cases per 100,000. Hence, the upsurge in tick-borne diseases is propelling the growth of the ticovac market. Boosted by the growth in research and development activities, the ticovac market is set for further expansion. Research and development (R&D) focus on creating new products, improving current ones, and innovating solutions through scientific and technical research to address emerging global challenges across different industries. This growing surge in R&D activities impacts TicoVac positively by driving progress in vaccine formulation and ensuring its ability to combat emerging strains of tick-borne encephalitis. For instance, in July 2024, the Department of Health and Social Care reported that $11.3 billion (£9.0 billion), representing 0.36% of the UK’s GDP, was committed by the business enterprise sector to pharmaceutical R&D in 2022 alone. This represented 18% of all business-based R&D in the UK for that year, the highest share among all product sectors. Therefore, escalation in research and development activities is fuelling the ticovac market’s growth.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19939&type=smp

#What Long-Term Growth Rate is Expected for theTicovac Market Between 2025 and 2034?

The ticovac market has expanded consistently, increasing from $4,010 million in 2024 to $4,310 million in 2025 at a CAGR of 7.6%. Growth was fueled by awareness initiatives, more travel to endemic regions, veterinary concerns, aging populations, and higher military immunization.

The ticovac market will grow to $5,700 million by 2029 at a CAGR of 7.3%, due to more outdoor activity, TBE incidence, and better healthcare coverage. Trends include new vaccine development and genomic advancements.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19939

What Are the Key Market Innovations in theTicovac Market Over the Coming Years?

In the ticovac market, the main trend is about advancing ingenious formulations such as suspension liquid to establish a competitive advantage. Suspension liquid is a vaccine composition designed to combat tick-borne encephalitis; it is administered via an intramuscular injection. This 0.5mL dose has been crafted for both adults and children. For example, in September 2024, Ticovac, a vaccine designed to prevent the viral infection of tick-borne encephalitis affecting the brain and spinal cord, was introduced by Pfizer Inc., a pharmaceutical manufacturer based in the United States. The vaccine marked the first defense against the disease in Japan, where the virus is widespread. Two formats of the vaccine are available, one for adults and the other for children, both in the form of a 0.5mL intramuscular injection.

Who Are the Top Companies Driving Innovation and Growth in theTicovac Market?

Major companies operating in the ticovac market include Pfizer Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/ticovac-global-market-report-

Which Key Market Segments Comprise the Ticovac Market and Drive Its Revenue Growth?

The ticovacmarket covered in this report is segmented –

1) By Formulation: Inactivated Vaccines; Live Attenuated Vaccines

2) By Indication: Tick-Borne Encephalitis; Japanese Encephalitis; Rabies Encephalitis

3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=19939&type=smp

Which Regions Are Emerging as Leaders in the Ticovac Market?

Europe was the largest region in the ticovac market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the ticovac market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Ticovac Market 2025, By The Business Research Company:

Prenatal Testing & Newborn Screening Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/prenatal-testing-and-newborn-screening-global-market-report

Prenatal And Newborn Genetic Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/prenatal-and-newborn-genetic-testing-global-market-report

Pertussis Vaccine Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pertussis-vaccine-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Enjoy a flat 15% OFF on all 2025 Global Market Reports until March 31st! Use code FY25SAVE to save big—don’t miss out!

What key factors are powering the surge in the ticovac market right now?

The market size of ticovac has seen substantial growth lately. Projected increase will be from $4,010 million in 2024 up to $4,310 million in 2025, with a Compound Annual Growth Rate (CAGR) that stands at 7.6%. The factors contributing to this expansion during the historical period include heightened awareness, an uptick in travel to endemic regions, escalating concerns in the veterinary sector, increases in the elderly population, and a rise in military and defense vaccinations.

How fast Is the ticovac market expected to grow, and what’s its future value?

In the coming years, the ticovac market is poised for robust growth, projected to reach a value of $5,700 million in 2029, with a compound annual growth rate (CAGR) of 7.3%. Factors contributing to this growth during the forecast period are an increase in outdoor workers, amplified healthcare spending, region-specific disease control focus, increased health insurance coverage, and a surge in tick-borne encephalitis (tbe) cases. Key trends during the forecast period comprise of technological advancements in vaccine production, the launch of new tbe vaccines, partnerships between governments and pharmaceutical companies, progress in genetic research, as well as advancements in surveillance and post-vaccination care.

Get your ticovac market report here!

https://www.thebusinessresearchcompany.com/report/ticovac-global-market-report-

What are the leading drivers of growth in the ticovac market?

The escalating incidence of diseases spread by ticks is set to propel the ticovac market growth onward. Human infections from diseases conveyed by ticks are increasing due to climate change, the expansion of tick environments, more human exposure, and improved diagnostic methods. Ticovac offers preventative protection against tick-borne encephalitis (TBE), a potentially hazardous virus transmitted via tick bites. To emphasise the point, in February 2024, data from the Centers for Disease Control and Prevention, a US government organization, indicated that the overall Lyme disease incident rate was 18.9 cases per 100,000 population. This was 68.8% higher than in prior years. In high-incidence areas, the median rate was 68.3 cases per 100,000, which is 58% higher, while the rate for children aged 5 to 9 years was 16.5 cases per 100,000, showing an 11.5% rise. Consequently, the increasing incidence of tick-borne diseases propels the growth of the ticovac market. Growth in the ticovac market is anticipated to be boosted by an upswing in research and development pursuits. Research and development (R&D) tasks include methodical analysis and novelty aimed at inventing new products, enhancing current ones, or evolving new technologies and solutions via scientific and technical study. The uptick in R&D activities is in response to the expanding demand for innovative solutions, progressive technological developments, and the urgency to tackle emerging universal trials across diverse industries. R&D pursuits positively affect TicoVac, leading to advancements in vaccine dosage formulation, boosting efficacy, and securing its constant capacity to counter emerging TBE strains. Furthermore, in July 2024, the Department of Health and Social Care, a UK government organization, reported that the business enterprise sector had spent $11.3 billion (£9.0 billion) on pharmaceutical R&D in 2022. This represented 0.36% of the UK’s GDP, with pharmaceutical R&D accounting for 18% of all business-related R&D, the most substantial proportion in all product sectors that year. Hence, this increase in research and development endeavors is fuelling the growth of the ticovac market.

What are the key segments defining the ticovac market?

The ticovacmarket covered in this report is segmented –

1) By Formulation: Inactivated Vaccines; Live Attenuated Vaccines

2) By Indication: Tick-Borne Encephalitis; Japanese Encephalitis; Rabies Encephalitis

3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19939&type=smp

Who are the key players steering the development of the ticovac market?

Major companies operating in the ticovac market include Pfizer Inc.

What emerging trends are influencing the growth of the ticovac market?

The ticovac market’s dominant trend is the concentration on unique formulations like suspension liquid to establish a strong market position. Suspension liquid is used as a vaccine solution against tick-borne encephalitis, which is offered as an intramuscular injection. With a dose of 0.5 mL, the suspension liquid is suitable for both adults and children. For example, Pfizer Inc., a pharmaceutical company headquartered in the US, introduced Ticovac in September 2024. This vaccine is designed to combat tick-borne encephalitis (TBE), a viral infection impacting the brain and spinal cord. Significantly, this is Japan’s first vaccine of this type, providing protection in areas where TBE is common. It is supplied in two versions, one for adults and one for children, both in a 0.5 mL intramuscular injection format.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19939

Which regions are most influential in expanding the ticovac market?

Europe was the largest region in the ticovac market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the ticovac market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Prenatal Testing & Newborn Screening Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/prenatal-testing-and-newborn-screening-global-market-report

Prenatal And Newborn Genetic Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/prenatal-and-newborn-genetic-testing-global-market-report

Pertussis Vaccine Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pertussis-vaccine-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How Will the CAGR of the Ticovac Market Influence Its Overall Growth by 2034?

There has been significant expansion in the ticovac market size over the past few years. The market is predicted to increase from $4,010 million in 2024 to $4,310 million in 2025, with a compound annual growth rate (CAGR) of 7.6%. The surge in the historic period can be linked to heightened awareness, more travel to disease-prone areas, escalating concerns in veterinary medicine, an aging population, and an increase in vaccinations in military and defense personnel.

Expectations are high for significant growth in the ticovac market size in the coming years. The market is projected to reach $5,700 million by 2029, increasing at a compound annual growth rate (CAGR) of 7.3%. Factors contributing to this anticipated growth during the forecasted period include an increase in outdoor workers, larger healthcare expenditure, a heightened focus on regional disease control, an expansion in health insurance coverage, and a rising number of tick-borne encephalitis (TBE) cases. Future trends expected to play a role in this market include technological improvements in vaccine production, the launch of new TBE vaccines, collaborations between governments and pharmaceutical corporations, advancements in genetic research, and progress in monitoring as well as post-vaccine care.

What Factors Are Propelling the Growth of the Ticovac Market from 2025 to 2034?

The predicted advancement in the ticovac market is largely related to the growing prevalence of diseases transmitted by ticks. Diseases caused by bacteria, viruses, or parasites, transferred to humans through the bite of infected ticks, are increasing because of factors such as climate change, enlarging tick habitats, more human contact, and improved diagnostic systems. Ticovac serves as an important prophylactic measure for these diseases, providing active immunization against tick-borne encephalitis (TBE), which is transmitted via tick bites and can potentially result in severe viral infection. Data compiled by the US Centers for Disease Control and Prevention in February 2024 indicates that the occurrence of Lyme disease was at 18.9 cases per 100,000 people, a 68.8% increase from prior years. In high-incidence areas, the median rate was 68.3 cases per 100,000, marking a 58% rise, and among children aged 5–9 years, the incidence was 16.5 cases per 100,000, an increase of 11.5%. Consequently, the cumulative effect of these factors augments the progression of the ticovac market.

Explore Comprehensive Insights Into The Global Ticovac Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19939&type=smp

Who Are the Leading Companies Pioneering Change in the Ticovac Market?

Major companies operating in the ticovac market include Pfizer Inc.

What Are the Most Significant Trends Transforming the Ticovac Market Today?

The ticovac market has been witnessing a significant trend involving the focus on cutting-edge formulations such as suspension liquid to secure a competitive advantage in the industry. This injection form of vaccine assists in preventing tick-borne encephalitis and can be administered intramuscularly. It is presented in a 0.5 mL dosage designed for both adults and children. In a noteworthy development in September 2024, Pfizer Inc., a pharmaceutical manufacturer from the USA, introduced Ticovac, a revolutionary vaccine intended to prevent tick-borne encephalitis (TBE), a viral infection impacting the brain and spinal cord. It is the pioneering vaccine of its kind in Japan, providing protection against the prevalent disease. The vaccine is offered in two variations, one for adults and another for children, both provided as a 0.5 mL intramuscular injection.

Secure Your Global Ticovac Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/ticovac-global-market-report-

What Are the Primary Segments of the Ticovac Market and Their Roles in Growth Dynamics?

The ticovacmarket covered in this report is segmented –

1) By Formulation: Inactivated Vaccines; Live Attenuated Vaccines

2) By Indication: Tick-Borne Encephalitis; Japanese Encephalitis; Rabies Encephalitis

3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

Which Regions Are Leading the Charge in Ticovac Market Development?

Europe was the largest region in the ticovac market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the ticovac market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Is the Definition of the Ticovac Market Impacting Future Growth?

TicoVac is a vaccine used to protect against tick-borne encephalitis (TBE), a viral disease transmitted primarily through tick bites or, less commonly, by consuming unpasteurized dairy products from infected animals. TBE affects the central nervous system and can lead to severe neurological complications, including meningitis and encephalitis. TicoVac works by stimulating the immune system to recognize and fight the tick-borne encephalitis virus (TBEV) if exposed in the future.

Browse Through More Similar Reports By The Business Research Company:

Prenatal Testing & Newborn Screening Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/prenatal-testing-and-newborn-screening-global-market-report

Prenatal And Newborn Genetic Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/prenatal-and-newborn-genetic-testing-global-market-report

Pertussis Vaccine Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pertussis-vaccine-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: